| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.094 | 0.6 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.6 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |